Literature DB >> 21839917

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises.

Annika Armulik1, Guillem Genové, Christer Betsholtz.   

Abstract

Pericytes, the mural cells of blood microvessels, have recently come into focus as regulators of vascular morphogenesis and function during development, cardiovascular homeostasis, and disease. Pericytes are implicated in the development of diabetic retinopathy and tissue fibrosis, and they are potential stromal targets for cancer therapy. Some pericytes are probably mesenchymal stem or progenitor cells, which give rise to adipocytes, cartilage, bone, and muscle. However, there is still confusion about the identity, ontogeny, and progeny of pericytes. Here, we review the history of these investigations, indicate emerging concepts, and point out problems and promise in the field of pericyte biology.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839917     DOI: 10.1016/j.devcel.2011.07.001

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  979 in total

1.  Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Authors:  Alexander M S Barron; Julio C Mantero; Jonathan D Ho; Banafsheh Nazari; Katharine L Horback; Jag Bhawan; Robert Lafyatis; Christina Lam; Jeffrey L Browning
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.

Authors:  Soon-Tae Lee; Youngbeom Seo; Ji-Yeon Bae; Kon Chu; Jin Wook Kim; Seung Hong Choi; Tae Min Kim; Il Han Kim; Sung-Hye Park; Chul-Kee Park
Journal:  Mol Neurobiol       Date:  2017-08-02       Impact factor: 5.590

Review 3.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 4.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

5.  Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration.

Authors:  Xiaowu Gu; Steven J Fliesler; You-Yang Zhao; William B Stallcup; Alex W Cohen; Michael H Elliott
Journal:  Am J Pathol       Date:  2013-12-08       Impact factor: 4.307

6.  Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.

Authors:  Manuel Valiente; Karuna Ganesh; Ekrem Emrah Er; Yilong Zou; Saloni Agrawal; Jing Hu; Bailey Griscom; Marc Rosenblum; Adrienne Boire; Edi Brogi; Filippo G Giancotti; Melitta Schachner; Srinivas Malladi; Joan Massagué
Journal:  Nat Cell Biol       Date:  2018-07-23       Impact factor: 28.824

Review 7.  Cellular and molecular regulation of vascular permeability.

Authors:  Lauren M Goddard; M Luisa Iruela-Arispe
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

8.  Peri-arterial specification of vascular mural cells from naïve mesenchyme requires Notch signaling.

Authors:  Koji Ando; Weili Wang; Di Peng; Ayano Chiba; Anne K Lagendijk; Lindsey Barske; J Gage Crump; Didier Y R Stainier; Urban Lendahl; Katarzyna Koltowska; Benjamin M Hogan; Shigetomo Fukuhara; Naoki Mochizuki; Christer Betsholtz
Journal:  Development       Date:  2019-01-25       Impact factor: 6.868

9.  Oxygen-Glucose Deprivation Induces G2/M Cell Cycle Arrest in Brain Pericytes Associated with ERK Inactivation.

Authors:  Wenjie Wei; Zhiyuan Yu; Minjie Xie; Wei Wang; Xiang Luo
Journal:  J Mol Neurosci       Date:  2016-09-24       Impact factor: 3.444

Review 10.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.